ClinicalTrials.gov
ClinicalTrials.gov Menu

End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01386723
Recruitment Status : Recruiting
First Posted : July 1, 2011
Last Update Posted : February 2, 2017
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
James B. Bussel, Weill Medical College of Cornell University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 30, 2019
  Estimated Study Completion Date : June 30, 2019